Compounds > dactinomycin

dactinomycin and iloprost

dactinomycin has been researched along with iloprost in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Hartley, R; Middleton, B; Nield, H1
Dinter, H; Frei, U; Gahl, GM; Jörres, A; Scholz, P; Topley, N1

Other Studies

3 other study(ies) available for dactinomycin and iloprost

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Cyclic AMP-mediated hormonal control of LDL receptor activity in cultured human cells.
    Biochemical Society transactions, 1993, Volume: 21, Issue:2

    Topics: Cells, Cultured; Cyclic AMP; Cycloheximide; Dactinomycin; Humans; Iloprost; Infant; Receptors, LDL

1993
Inhibition of tumour necrosis factor production in endotoxin-stimulated human mononuclear leukocytes by the prostacyclin analogue iloprost: cellular mechanisms.
    Cytokine, 1997, Volume: 9, Issue:2

    Topics: Cells, Cultured; Dactinomycin; Epoprostenol; Humans; Iloprost; Leukocytes, Mononuclear; Lipopolysaccharides; Mitogens; Nucleic Acid Synthesis Inhibitors; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha

1997